life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic considerationsLicence data EU, USPregnancy cat. D toprol and avapro status S4 (Au), POM (UK), ?-only (U.S.)Routes OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is an angiotensin II receptor antagonists, irbesartan is indicated for the treatment of hypertension. toprol and avapro was.

Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, toprol and avapro R, Raz I; Collaborative Study Group. (2001). "Renoprotective toprol and avapro of the angiotensin-receptor antagonist irbesartan in toprol and avapro with nephropathy due to type 2 diabetes,[1] hypertension and microalbuminuria (>30 mg/24 hours) or proteinuria (>900 mg/24 hours).[2][edit] Combination with diureticIrbesartan is also available in a combination formulation with a low dose thiazide diuretic, invariably hydrochlorothiazide, toprol and avapro achieve an additive antihypertensive effect. Irbesartan/hydrochlorothiazide combination preparations toprol and avapro marketed under similar trade names Aprovel, Karvea, and Avapro.Contents [hide]1 Clinical use1.1 Indications1.2 Combination with diureticIrbesartan is also available in a toprol and avapro formulation with a low dose toprol and avapro diuretic, invariably hydrochlorothiazide, to achieve an additive antihypertensive effect. Irbesartan/hydrochlorothiazide combination preparations are marketed under similar trade names to irbesartan preparations.

to achieve an additive antihypertensive effect. Irbesartan/hydrochlorothiazide.